← SynDRA
GW-5074
SynDRA canonical compound SYN1969496 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
|---|
| Primary target(s) | LRRK1 | LRRK2 | NTRK1 | RAF1 |
|---|
| Mechanism of action | leucine rich repeat kinase inhibitor | RAF inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- leucine rich repeat kinase inhibitor
- RAF inhibitor
Cross-references
Synonyms
- GW 5074
- gw5074
- Raf1 Kinase Inhibitor I
- UNII-B7W8RS1GG2
- B7W8RS1GG2
- CHEMBL72365
- 5-Iodo-3-[(3,5-dibromo-4-hydroxyphenyl)methylene]-2-indolinone
- 3-(3,5-Dibromo-4-hydroxy-benzylidene)-5-iodo-1,3-dihydro-indol-2-one
- (3Z)-3-[(3,5-dibromo-4-hydroxyphenyl)methylidene]-5-iodo-1H-indol-2-one
- (Z)-3-(3,5-Dibromo-4-hydroxybenzylidene)-5-iodoindolin-2-one
- SR-01000075897
- STO521
- 3-(3,5-Dibromo-4-hydroxybenzyliden)-5-iodo-1,3-dihydroindol-2-one
- Tocris-1381
Look up GW-5074 in the interactive SynDRA portal →